Chartwell Investment Partners’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-35,866
| Closed | -$996K | – | 414 |
|
|
2019
Q2 | $996K | Sell |
35,866
-3,530
| -9% | -$98K | 0.03% | 381 |
|
|
2019
Q1 | $1.31M | Sell |
39,396
-671
| -2% | -$22.3K | 0.04% | 373 |
|
|
2018
Q4 | $1.17M | Buy |
40,067
+276
| +0.7% | +$8.03K | 0.04% | 393 |
|
|
2018
Q3 | $1.83M | Sell |
39,791
-3,725
| -9% | -$171K | 0.05% | 398 |
|
|
2018
Q2 | $1.63M | Sell |
43,516
-1,025
| -2% | -$38.3K | 0.05% | 401 |
|
|
2018
Q1 | $1.32M | Sell |
44,541
-76,005
| -63% | -$2.25M | 0.05% | 349 |
|
|
2017
Q4 | $4.14M | Buy |
120,546
+28,831
| +31% | +$990K | 0.14% | 230 |
|
|
2017
Q3 | $3.32M | Sell |
91,715
-61,000
| -40% | -$2.21M | 0.11% | 251 |
|
|
2017
Q2 | $3.95M | Hold |
152,715
| – | – | 0.15% | 191 |
|
|
2017
Q1 | $2.93M | Buy |
152,715
+33,000
| +28% | +$634K | 0.11% | 236 |
|
|
2016
Q4 | $2M | Hold |
119,715
| – | – | 0.07% | 313 |
|
|
2016
Q3 | $2.46M | Buy |
119,715
+35,000
| +41% | +$720K | 0.04% | 331 |
|
|
2016
Q2 | $2.59M | Buy |
+84,715
| New | +$2.59M | 0.05% | 304 |
|